- Home
- ALX vs MDXG Comparison
ALX vs MDXG Comparison
Compare ALX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALX | MDXG |
|---|---|---|
| Founded | 1928 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALX | MDXG |
|---|---|---|
| Price | $230.57 | $3.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 41.7K | ★ 825.3K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 5.50 | 0.32 |
| Revenue | $213,183,000.00 | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | $41.38 | ★ $12.34 |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $189.05 | $3.77 |
| 52 Week High | $260.84 | $7.99 |
Technical Indicators
Market Signals| Indicator | ALX | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 27.63 |
| Support Level | $229.26 | N/A |
| Resistance Level | $235.65 | $7.39 |
| Average True Range (ATR) | 6.89 | 0.15 |
| MACD | -1.52 | 0.00 |
| Stochastic Oscillator | 22.11 | 16.67 |
Price Performance
Historical ComparisonAbout ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.